Primary Site >> Liver Cancer
Gene >> CCL5
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. PMID: 17413295 Ref: Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. PMID: 18025279 |
Ref: Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. PMID: 18205260 |
Ref: Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. PMID: 19632304 Ref: Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. PMID: 19838081 Ref: Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C. PMID: 20428640 |
Ref: Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. PMID: 22042469 |
Ref: Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. PMID: 21930732 Ref: Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. PMID: 22267597 Ref: CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma. PMID: 22374185 |
Ref: The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma. PMID: 23292657 Ref: Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma. PMID: 23402366 Ref: p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. PMID: 24043758 |
Ref: CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway. PMID: 24806733 Ref: Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group. PMID: 24890858 Ref: Roles for chemokines in liver disease. PMID: 25066692 |
Ref: Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells. PMID: 26151573 Ref: CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates. PMID: 26192559 Ref: Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. PMID: 26270232 |
Ref: Interfering with CCL5/CCR5 at the Tumor-Stroma Interface. PMID: 27070698 Ref: Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. PMID: 27070705 Ref: Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-beta pathways. PMID: 27216982 Ref: In Vitro Protective Effects of Lycium barbarum Berries Cultivated in Umbria (Italy) on Human Hepatocellular Carcinoma Cells. PMID: 27965980 |
Ref: Functional role of CCL5/RANTES for HCC progression during chronic liver disease. PMID: 28011329 Ref: Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin. PMID: 28373218 Ref: Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma. PMID: 28592115 Ref: IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma. PMID: 29073625 |
Ref: Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. PMID: 29440463 Ref: Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. PMID: 29665135 |